The CEO is a shareholder, & she is building prospective global value on Earth 🌎 through a growing pipeline, automated manufacturing, comprehensive patent-fortified global IP portfolio, & relationships with world-renowned researchers & academic institutions…
UCLA, Roswell, & Pitt are on the cutting edge of a dawning new era of targeted individualized immuno-oncology technologies! There are small but significant COMBO trials that have reached PII already, & every recent quarterly & annual SEC filing has made reference to further COMBO research with TLR or other agents…
“All solid tumors” or “most solid tumors” are quotes from the company that come from SEC filings, press releases, & scientific conferences.
Additionally, the company has referenced DCVax & the Roswell technology as potential treatments for multiple types of cancer, & they have cited clinical data from an earlier trial & compassionate use…
Fact ✅: There was a time in recent history when NWBO had only ONE asset…
NWBO now has FIVE+ asset categories & the company’s clinical pipeline has expanded. Shorts are finding their position more & more precarious with each step of progress.. that is the reason why we see the fud flood here 24/7
AI
